Assessment of clinical characteristics and viral load in individuals infected by Delta and Omicron variants of SARS-CoV-2
- PMID: 37600420
- PMCID: PMC10432967
- DOI: 10.1016/j.heliyon.2023.e18994
Assessment of clinical characteristics and viral load in individuals infected by Delta and Omicron variants of SARS-CoV-2
Abstract
In late 2021, a new variant of SARS-CoV-2 called Omicron emerged, replacing Delta worldwide. Although it has been associated with a lower risk of hospitalization and severe forms of COVID-19, there is little evidence of its relationship with specific symptoms and viral load. The aim of this study was to verify the relationship between Delta and Omicron variants of concern, viral load, and the occurrence of symptoms in individuals with COVID-19. Nasopharyngeal swab samples were collected and sequenced from patients with COVID-19 from the Northeast Region of Brazil between August 2021 and March 2022. The results showed a gradual replacement of the Delta variant by the Omicron variant during the study period. A total of 316 samples (157 Delta and 159 Omicron) were included. There was a higher prevalence of symptoms in Delta-infected individuals, such as coryza, olfactory and taste disturbances, headache, and myalgia. There was no association between viral load and the variants analyzed. The results reported here contribute to the understanding of the symptoms associated with the Delta and Omicron variants in individuals affected by COVID-19.
Keywords: COVID-19; Delta; Omicron; Symptoms; Variants of concern; Viral load.
© 2023 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Rodrigo Feliciano do Carmo reports financial support was provided by Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE). Associate Editor of Heliyon - Rodrigo Feliciano do Carmo.
Figures
References
-
- World Health Organization. Tracking SARS-CoV-2 Variants. Accessed January 31, 2023.https://www.who.int/activities/tracking-SARS-CoV-2-variants.
-
- Greene S.K., Levin-Rector A., Kyaw N.T.T., et al. Influenza Other Respir Viruses. Published online 2022; New York City: August 2021–January 2022. Comparative Hospitalization Risk for SARS-CoV-2 Omicron and Delta Variant Infections, by Variant Predominance Periods and Patient-Level Sequencing Results. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
